Gepubliceerd in:

03-02-2021 | Original Article

Serum Galanin in Children with Autism Spectrum Disorder

Auteurs: Khaled Saad, Ahmed A. Abdel-Rahman, Abdulrahman A. Al-Atram, Alam-Eldin M. Abdallah, Amira Elhoufey, Eman M. Nagiub Abdelsalam, Dalia A. Nigm, Ola Elshora, Ahmad Roshdy Ahmad, Mohamed M. El-Tellawy, Khaled Hashim Mahmoud

Gepubliceerd in: Child Psychiatry & Human Development | Uitgave 2/2022

Abstract

Recent studies have attempted to measure several biomarkers to understand the complex interactions of the anatomic systems that may be involved in autism spectrum disorder (ASD). In CNS, galanin takes part in a variety of pathological and physiological processes. Prior research has indicated it is involved in several neuropsychiatric disorders and has a role in inhibiting the neuronal firing and release of serotonin, norepinephrine, and acetylcholine. To date, serum galanin levels have not been investigated in the context of ASD. This study aimed, therefore, to compare the serum galanin levels of children with ASD and healthy controls and to reveal any association between galanin level and the severity of ASD, as well as other psychological and demographic parameters. Serum galanin levels were measured by radioimmunoassay in 116 children with ASD and 98 healthy children. We observed significantly increased serum concentrations of galanin in children with ASD relative to healthy children. Moreover, children with severe ASD had significantly higher galanin levels than those with less severe disease. We also confirmed significant positive correlations between galanin and psychiatric parameters in children with ASD. For the first time, we suggest a possible correlation between serum galanin and the degree of ASD severity. Increased galanin levels may play a role in the pathogenesis of ASD.

vorige artikel Emergency Department Visits for Non-suicidal Self-harm, Suicidal Ideation, and Suicide Attempts in Children and Adolescents

volgende artikel The Study of Developmental Risk Factors for Early Fire Involvement

Bjørklund G, Kern JK, Urbina MA, Saad K, El-Houfey AA, Geier DA, Chirumbolo S, Geier MR, Mehta JA, Aaseth J (2018) Cerebral hypoperfusion in autism spectrum disorder. Acta Neurobiol Exp 78(1):21–29. https://doi.org/10.21307/ane2018005CrossRef

Bjørklund G, Waly MI, Al-Farsi Y, Saad K, Dadar M, Rahman MM, Elhoufey A, Chirumbolo S, Jóźwik-Pruska J, Kałużna-Czaplińska J (2019) The role of vitamins in autism spectrum disorder: what do we know? J Mol Neurosci: MN 67(3):373–387. https://doi.org/10.1007/s12031-018-1237-5CrossRefPubMed

Bjørklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, Hemimi M, Skalny AV, Hosnedlová B, Kizek R, Osredkar J, Urbina MA, Fabjan T, El-Houfey AA, Kałużna-Czaplińska J, Gątarek P, Chirumbolo S (2020) Oxidative stress in autism spectrum disorder. Mol Neurobiol. https://doi.org/10.1007/s12035-019-01742-2CrossRefPubMedPubMedCentral

Karlsson RM, Holmes A (2006) Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease. Amino Acids 31(3):231–239. https://doi.org/10.1007/s00726-006-0336-8CrossRefPubMed

Millón C, Flores-Burgess A, Narváez M, Borroto-Escuela DO, Santín L, Parrado C, Narváez JA, Fuxe K, Díaz-Cabiale Z (2014) A role for galanin N-terminal fragment (1–15) in anxiety- and depression-related behaviors in rats. Int J Neuropsychopharmacol 18(3):pyu064. https://doi.org/10.1093/ijnp/pyu064CrossRefPubMed

Wang YJ, Yang YT, Li H, Liu PZ, Wang CY, Xu ZQ (2014) Plasma Galanin is a biomarker for severity of major depressive disorder. Int J Psychiatry Med 48(2):109–119. https://doi.org/10.2190/PM.48.2.dCrossRefPubMed

Keszler G, Molnár Z, Rónai Z, Sasvári-Székely M, Székely A, Kótyuk E (2019) Association between anxiety and non-coding genetic variants of the galanin neuropeptide. PLoS ONE 14(12):e0226228. https://doi.org/10.1371/journal.pone.0226228CrossRefPubMedPubMedCentral

Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, Díaz-Cabiale Z, Fuxe K (2010) Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Commun 393(4):767–772. https://doi.org/10.1016/j.bbrc.2010.02.078CrossRefPubMed

Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115(2):177–207. https://doi.org/10.1016/j.pharmthera.2007.05.009CrossRefPubMed

10.

Lang R, Gundlach AL, Holmes FE, Hobson SA, Wynick D, Hökfelt T, Kofler B (2015) Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity. Pharmacol Rev 67(1):118–175. https://doi.org/10.1124/pr.112.006536CrossRefPubMed

11.

Pirondi S, Kuteeva E, Giardino L, Ferraro L, Antonelli T, Bartfai T, Ogren SO, Hökfelt T, Calzà L (2005) Behavioral and neurochemical studies on brain aging in galanin overexpressing mice. Neuropeptides 39(3):305–312. https://doi.org/10.1016/j.npep.2005.02.006CrossRefPubMed

12.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders 5. American Psychiatric Association, Washington, DCCrossRef

13.

Lord C, Rutter M, Le Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659–685. https://doi.org/10.1007/bf021721451600CrossRefPubMed

14.

Schopler E, Van Bourgondien ME, Wellman GJ (2010) Childhood Autism Rating Scale, 2nd edn. Western Psychological Services, Los Angeles

15.

Jia F, Shan L, Wang B, Li H, Miao C, Xu Z, Lin CP, Saad K (2018) Bench to bedside review: possible role of vitamin D in autism spectrum disorder. Psychiatry Res 260:360–365. https://doi.org/10.1016/j.psychres.2017.12.005CrossRefPubMed

16.

Saad K, Abdallah AM, Abdel-Rahman AA, Al-Atram AA, Abdel-Raheem YF, Gad EF, Abo-Elela M, Elserogy YM, Elhoufey A, Nigm DA, Nagiub Abdelsalam EM, Alruwaili T (2020) Polymorphism of interleukin-1β and interleukin-1 receptor antagonist genes in children with autism spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 103:109999. https://doi.org/10.1016/j.pnpbp.2020.109999CrossRefPubMed

17.

Šípková J, Kramáriková I, Hynie S, Klenerová V (2017) The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions. Physiol Res 66(5):729–740. https://doi.org/10.33549/physiolres.933576CrossRefPubMed

18.

Hohmann JG, Juréus A, Teklemichael DN, Matsumoto AM, Clifton DK, Steiner RA (2003) Distribution and regulation of galanin receptor 1 messenger RNA in the forebrain of wild type and galanin-transgenic mice. Neuroscience 117(1):105–117. https://doi.org/10.1016/s0306-4522(02)00798-4CrossRefPubMed

19.

Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hökfelt T, Wolinsky TD, Konkel MJ, Chen H, Zhong H, Walker MW, Craig DA, Gerald CP, Branchek TA (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci USA 102(48):17489–17494. https://doi.org/10.1073/pnas.0508970102CrossRefPubMedPubMedCentral

20.

Elserogy Y, Saad K, Al-Atram AA, Othman HA, El-Baseer K, Ahmed AE (2017) Chromosomal aberrations in children with autism spectrum disorders in Upper Egypt. Anatol J Psychiatry 18(3):243–249. https://doi.org/10.5455/apd.244540CrossRef

21.

Ogren SO, Schött PA, Kehr J, Misane I, Razani H (1999) Galanin and learning. Brain Res 848(1–2):174–182. https://doi.org/10.1016/s0006-8993(99)01973-3CrossRefPubMed

22.

Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG (2000) Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20(16):6276–6281. https://doi.org/10.1523/JNEUROSCI.20-16-06276.2000CrossRefPubMedPubMedCentral

23.

Pieribone VA, Xu ZQ, Zhang X, Hökfelt T (1998) Electrophysiologic effects of galanin on neurons of the central nervous system. Ann N Y Acad Sci 863:264–273. https://doi.org/10.1111/j.1749-6632.1998.tb10701.xCrossRefPubMed

24.

Rovin ML, Boss-Williams KA, Alisch RS, Ritchie JC, Weinshenker D, West CH, Weiss JM (2012) Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Neuropeptides 46(2):81–91. https://doi.org/10.1016/j.npep.2012.01.001CrossRefPubMedPubMedCentral

25.

Saad K, Zahran AM, Elsayh KI, Abdel-Rahman AA, Al-Atram AA, Hussein A, El-Gendy YG (2017) Frequency of dendritic cells and their expression of costimulatory molecules in children with autism spectrum disorders. J Autism Dev Disord 47(9):2671–2678. https://doi.org/10.1007/s10803-017-3190-5CrossRefPubMed

26.

Juhasz G, Hullam G, Eszlari N, Gonda X, Antal P, Anderson IM, Hökfelt TG, Deakin JF, Bagdy G (2014) Brain galanin system genes interact with life stresses in depression-related phenotypes. Proc Natl Acad Sci USA 111(16):E1666–E1673. https://doi.org/10.1073/pnas.1403649111CrossRefPubMedPubMedCentral

27.

Bajo M, Madamba SG, Lu X, Sharkey LM, Bartfai T, Siggins GR (2012) Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala. Addict Biol 17(4):694–705. https://doi.org/10.1111/j.1369-1600.2011.00360.xCrossRefPubMed

Titel: Serum Galanin in Children with Autism Spectrum Disorder
Auteurs: Khaled Saad
Ahmed A. Abdel-Rahman
Abdulrahman A. Al-Atram
Alam-Eldin M. Abdallah
Amira Elhoufey
Eman M. Nagiub Abdelsalam
Dalia A. Nigm
Ola Elshora
Ahmad Roshdy Ahmad
Mohamed M. El-Tellawy
Khaled Hashim Mahmoud
Publicatiedatum: 03-02-2021
Uitgeverij: Springer US
Gepubliceerd in: Child Psychiatry & Human Development / Uitgave 2/2022
Print ISSN: 0009-398X
Elektronisch ISSN: 1573-3327
DOI: https://doi.org/10.1007/s10578-021-01127-4

Andere artikelen Uitgave 2/2022

Psychopharmacological Treatments in Children with Fetal Alcohol Spectrum Disorders: A Review

Article

Fathers’ Mental Health and Children’s Aggressive Behaviour A Study Based on Data from the Norwegian Mother, Father and Child Cohort Study (MoBa)

Open Access
Original Article

The Positive Effect of the Rational Addiction Prevention Program (RAPP) on Adolescents with High Risk for Drug Consumption

Original Article

Correction to: The Bright Side of Grit in Burnout-Prevention: Exploring Grit in the Context of Demands-Resources Model among Chinese High School Students

Open Access
Correction

Long-Term Mental Health and Quality of Life Outcomes of Neonatal Insults in Kilifi, Kenya

Open Access
Original Article

Reducing the Nighttime Fears of Young Children Through a Brief Parent-Delivered Treatment—Effectiveness of the Hungarian Version of Uncle Lightfoot

Open Access
Original Article